Narrative piece by Julian published in Annals of Internal Medicine
Dr. Kathleen Julian, professor of medicine at Penn State College of Medicine and a member of the Department of Medicine‘s Division of Infectious Diseases and Epidemiology, recently published a narrative piece in the Annals of Internal Medicine journal.
Julian’s empathetic reflection calls attention to the early days of the COVID-19 pandemic and the path forward for both patients and health care providers provided by participation in randomized controlled clinical trials.
Julian was a member of the National Institutes of Health-sponsored Adaptive COVID-19 Treatment Trial along with other infectious diseases division members including Dr. Catharine Paules, associate professor of medicine and site principle investigator, Dr. Rezhan Hussein, associate professor of medicine, and Dr. Tonya Crook, associate professor of medicine, as well as members of the Division of Hospital Medicine and Division of Pulmonary, Allergy and Critical Care Medicine. Numerous dedicated support staff also contributed to the clinical trial.
This network led to the U.S. Food and Drug Administration’s approval of two widely used COVID-19 therapeutic agents, Remdesivir and Baricitinib.
If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.